CVS Health Corporation (CVS)

Basic

  • Market Cap

    $95.24B

  • EV

    $159.32B

  • Shares Out

    1,286.9M

  • Revenue

    $346.6B

  • Employees

    259,500

Margins

  • Gross

    15.29%

  • EBITDA

    5.29%

  • Operating

    4.05%

  • Pre-Tax

    3.29%

  • Net

    2.44%

  • FCF

    3.26%

Returns (5Yr Avg)

  • ROA

    3.91%

  • ROE

    7.37%

  • ROCE

    8.53%

  • ROIC

    3.49%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $88.3

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $268.63

  • Earnings (Dil)

    $6.53

  • FCF

    $8.72

  • Book Value

    $57.76

Growth (CAGR)

  • Rev 3Yr

    9.32%

  • Rev 5Yr

    13.01%

  • Rev 10Yr

    10.71%

  • Dil EPS 3Yr

    2.59%

  • Dil EPS 5Yr

    16.51%

  • Dil EPS 10Yr

    6.19%

  • Rev Fwd 2Yr

    3.49%

  • EBITDA Fwd 2Yr

    -0.18%

  • EPS Fwd 2Yr

    -0.98%

  • EPS LT Growth Est

    4.89%

Dividends

  • Yield

    —

  • Payout

    36.03%

  • DPS

    $2.37

  • DPS Growth 3Yr

    5.75%

  • DPS Growth 5Yr

    3.41%

  • DPS Growth 10Yr

    10.94%

  • DPS Growth Fwd 2Yr

    5.12%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

193,919.0

255,765.0

267,908.0

290,912.0

321,629.0

346,601.0

Total Revenues % Chg.

5.0%

31.9%

4.7%

8.6%

10.6%

10.3%

Cost of Goods Sold, Total

163,041.0

211,248.0

219,660.0

240,063.0

268,173.0

293,603.0

Gross Profit

30,878.0

44,517.0

48,248.0

50,849.0

53,456.0

52,998.0

Selling General & Admin Expenses, Total

20,827.0

32,699.0

34,585.0

36,809.0

38,039.0

38,953.0

Other Operating Expenses, Total

20,827.0

32,699.0

34,585.0

36,809.0

38,039.0

38,953.0

Operating Income

10,051.0

11,818.0

13,663.0

14,040.0

15,417.0

14,045.0

Interest Expense, Total

-2,619.0

-3,035.0

-2,907.0

-2,503.0

-2,287.0

-2,520.0

Interest And Investment Income

660.0

1,011.0

798.0

1,199.0

838.0

1,208.0

Net Interest Expenses

-1,959.0

-2,024.0

-2,109.0

-1,304.0

-1,449.0

-1,312.0

Other Non Operating Income (Expenses)

-2.0

-7.0

-12.0

-4.0

-4.0

-62.0

EBT, Excl. Unusual Items

8,090.0

9,787.0

11,542.0

12,732.0

13,964.0

12,671.0

Restructuring Charges

—

-231.0

—

-1,358.0

—

-507.0

Merger & Related Restructuring Charges

-492.0

-480.0

-332.0

-132.0

—

-294.0

Impairment of Goodwill

-6,149.0

—

—

-431.0

—

—

Gain (Loss) On Sale Of Assets

—

—

—

—

-2,533.0

-361.0

Asset Writedown

-43.0

—

—

—

—

—

Legal Settlements

—

—

—

—

-5,803.0

-99.0

Other Unusual Items

—

-79.0

-1,440.0

-391.0

—

—

EBT, Incl. Unusual Items

1,406.0

8,997.0

9,770.0

10,420.0

5,628.0

11,410.0

Income Tax Expense

2,002.0

2,366.0

2,569.0

2,522.0

1,463.0

2,919.0

Earnings From Continuing Operations

-596.0

6,631.0

7,201.0

7,898.0

4,165.0

8,491.0

Earnings Of Discontinued Operations

—

—

-9.0

—

—

—

Minority Interest

2.0

3.0

-13.0

12.0

-16.0

-21.0

Net Income

-594.0

6,634.0

7,179.0

7,910.0

4,149.0

8,470.0

Preferred Dividend and Other Adjustments

3.0

5.0

—

—

—

—

Net Income to Common Incl Extra Items

-597.0

6,629.0

7,179.0

7,910.0

4,149.0

8,470.0

Net Income to Common Excl. Extra Items

-597.0

6,629.0

7,188.0

7,910.0

4,149.0

8,470.0

Total Shares Outstanding

1,295.0

1,302.0

1,310.0

1,322.0

1,300.0

1,287.0

Weighted Avg. Shares Outstanding

1,044.0

1,301.0

1,309.0

1,319.0

1,312.0

1,290.3

Weighted Avg. Shares Outstanding Dil

1,044.0

1,305.0

1,314.0

1,329.0

1,323.0

1,296.8

EPS

-0.6

5.1

5.5

6.0

3.2

6.6

EPS Diluted

-0.6

5.1

5.5

6.0

3.1

6.5

EBITDA

12,769.0

16,189.0

18,104.0

18,552.0

19,664.0

18,343.0